Risk factors for the primary effectiveness endpoint in secondary prevention of acute coronary syndrome with antiplatelet agents: A cohort in the nationwide French claims and hospitalisation database
Conclusions In this nationwide real-life study, the risk factor most associated with the primary effectiveness endpoint was a Charlson comorbidity index>5.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Clopidogrel | Congestive Heart Failure | Databases & Libraries | Diabetes | Endocrinology | France Health | Heart | Heart Failure | Hypertension | Intensive Care | Ischemic Stroke | Plavix | Stroke | Study